Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study

INTRODUCTION: Previous studies suggested that β-cell function markers such as fasting and postprandial serum C-peptide and C-peptide increment (FCPR, PCPR, and ΔCPR, respectively) may be useful in estimating glycemic response to glucagon-like peptide-1 receptor agonists. However, it remains elusive...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshiji, Satoshi, Hasebe, Masashi, Iwasaki, Yorihiro, Shibue, Kimitaka, Keidai, Yamato, Seno, Yohei, Iwasaki, Kanako, Honjo, Sachiko, Fujikawa, Jun, Hamasaki, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991285/
https://www.ncbi.nlm.nih.gov/pubmed/35285007
http://dx.doi.org/10.1007/s13300-022-01231-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991285/
https://www.ncbi.nlm.nih.gov/pubmed/35285007
http://dx.doi.org/10.1007/s13300-022-01231-1

Ejemplares similares